Utility of Liver Biopsy in Diagnosis and Management of High-grade Immune Checkpoint Inhibitor Hepatitis in Patients With Cancer.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 34554206.
- Also identified by DOI 10.1001/jamaoncol.2021.4342 and PMC identifier 8461544.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study examines the association of liver biopsy with management and outcomes of high-grade immune checkpoint inhibitor hepatitis.
Medical subject headings
- Hepatitis
- Neoplasms